AKT1 and osteosarcoma: Also, treatment with DATS decreases cell viability and proliferation in gastric cancer 118, osteosarcoma 119, and glioma 123 through the activation of MAPK and suppression of PI3K/AKT cascades, and wingless integrated (Wnt)/beta catenin (ꞵ-catenin) pathways respectively.